Live Breaking News & Updates on Michael Kotsanis

Stay updated with breaking news from Michael kotsanis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Guess which ASX healthcare stock is rocketing 110% on US product launch

Guess which ASX healthcare stock is rocketing 110% on US product launch
fool.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com.au Daily Mail and Mail on Sunday newspapers.

United States , Michael Kotsanis , Bausch Health , Acrux Ltd , Acyclovir Cream , Zovirax Cream ,

Dr Boreham's Crucible: IDT Australia

Tim Boreham outlines the rise and fall of IDT Australia, and its potential revival in the cannabis and psychedelic drug market ....

Mary Sontrop , Morgan Stanley , Paul Mcdonald , Jan Ryan , Mark Simari , Tim Boreham , Michael Kotsanis , Paul Macleman , Alan Fisher , Graeme Blackman , Hugh Burrill , Geoff Sam , Institute Of Drug Technology , Australian Therapeutics Goods Administration , Health Department , Victorian College Of Pharmacy , Small Caps , Sandon Capital , Regal Funds Management , Federal Health Department , Drug Technology , Victorian College , Paragon Care ,

IDT Australia announces new appointments to board of directors

IDT Australia announces new appointments to board of directors
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Michael Kotsanis , Mark Simari , Hugh Burrill , Geoffrey Sam , Tali Digital , Paragon Care , Healthe Care , Non Executive Directors ,

ASX stock of the day: Acrux (ASX:ACR) shares soar 36% on FDA approval

ASX stock of the day: Acrux (ASX:ACR) shares soar 36% on FDA approval
Sebastian Bowen | January 12, 2021 4:06pm |
More on:
The
Acrux Limited(ASX: ACR) share price is soaring today, up 36.36% at the time of writing to 22 cents a share.
Acrux shares closed at 16 cents a share yesterday but opened at 28 cents a share this morning before soaring all the way up to a high of 32 cents soon after. Even though Acrux has somewhat cooled off since, these new heights represent a 52-week high for the company.
So who is Acrux? And why are Acrux shares so convincingly on the march today? ....

United States , Scott Phillips , Michael Kotsanis , Acrux Limited , Drug Administration , Dash Pharmaceuticals , Testosterone Topical Solution , Motley Fool Share Advisor , ஒன்றுபட்டது மாநிலங்களில் , ஸ்காட் பிலிப்ஸ் , ஆகிருஸ் வரையறுக்கப்பட்டவை , கோடு மருந்துகள் , டெஸ்டோஸ்டிரோன் மேற்பூச்சு தீர்வு ,

Acrux : Raises $7.8m Via Placement and Announces SPPOpens in a new Window

Acrux : Raises $7.8m Via Placement and Announces SPPOpens in a new Window
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

New Zealand , Michael Kotsanis , Acrux Limited , Phillip Asset Management Limited , Bioscience Managers Translation Fund , Company Significant Interest , Media Release , Purchase Plan , Significant Interest , Managing Director , Bioscience Managers , Eligible Shareholder , Eligible Shareholders , Application Form , Application Forms , புதியது ஜீலாந்து , ஆகிருஸ் வரையறுக்கப்பட்டவை , பிலிப் சொத்து மேலாண்மை வரையறுக்கப்பட்டவை , உயிர் அறிவியல் மேலாளர்கள் மொழிபெயர்ப்பு நிதி , நிறுவனம் குறிப்பிடத்தக்க ஆர்வம் , மீடியா வெளியீடு , கொள்முதல் திட்டம் , குறிப்பிடத்தக்க ஆர்வம் , நிர்வகித்தல் இயக்குனர் , உயிர் அறிவியல் மேலாளர்கள் , தகுதியானவர் பங்குதாரர் ,